Paula M. Kujala

Tampere, Finland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 56 publications

Risk factors for low-risk prostate cancer: A retrospective cohort study within the FinRSPC trial.

Risk factors for low-risk prostate cancer: A retrospective cohort study within the FinRSPC trial.

Journal: International journal of cancer

Published: December 18, 2024

Do differences in secondary treatment explain mortality impact of prostate cancer screening? - A randomized screening trial.

Do differences in secondary treatment explain mortality impact of prostate cancer screening? - A randomized screening trial.

Journal: Urologic oncology

Published: October 13, 2024

Long-term Risk of Prostate Cancer Mortality Among Men with Baseline Prostate-specific Antigen Below 3 ng/ml: Evidence from the Finnish Randomized Study of Screening for Prostate Cancer.

Long-term Risk of Prostate Cancer Mortality Among Men with Baseline Prostate-specific Antigen Below 3 ng/ml: Evidence from the Finnish Randomized Study of Screening for Prostate Cancer.

Journal: European urology oncology

Published: August 17, 2024

Screening history and risk of death from prostate cancer: a nested case-control study within the screening arm of the Finnish Randomized Study of Screening for Prostate Cancer (FinRSPC).

Screening history and risk of death from prostate cancer: a nested case-control study within the screening arm of the Finnish Randomized Study of Screening for Prostate Cancer (FinRSPC).

Journal: Cancer causes & control : CCC

Published: September 14, 2023

Cancer origin tracing and timing in two high-risk prostate cancers using multisample whole genome analysis: prospects for personalized medicine.

Cancer origin tracing and timing in two high-risk prostate cancers using multisample whole genome analysis: prospects for personalized medicine.

Journal: Genome medicine

Published: April 13, 2023

Cytohistological findings in HPV-negative cases from HPV primary screening programme: quality assurance study.

Cytohistological findings in HPV-negative cases from HPV primary screening programme: quality assurance study.

Journal: APMIS : acta pathologica, microbiologica, et immunologica Scandinavica

Published: July 13, 2022

Prostate cancer incidence in men with prostate-specific antigen below 3 ng/mL: The Finnish Randomized Study of Screening for Prostate Cancer.

Prostate cancer incidence in men with prostate-specific antigen below 3 ng/mL: The Finnish Randomized Study of Screening for Prostate Cancer.

Journal: International journal of cancer

Published: April 20, 2022

Population-based randomized trial of screening for clinically significant prostate cancer ProScreen: a pilot study.

Population-based randomized trial of screening for clinically significant prostate cancer ProScreen: a pilot study.

Journal: BJU international

Published: December 27, 2021

Tumour Suppressor Neuron Navigator 3 and Matrix Metalloproteinase 14 are Co-expressed in Most Melanomas but Downregulated in Thick Tumours.

Tumour Suppressor Neuron Navigator 3 and Matrix Metalloproteinase 14 are Co-expressed in Most Melanomas but Downregulated in Thick Tumours.

Journal: Acta dermato-venereologica

Published: October 07, 2021

Combined Longitudinal Clinical and Autopsy Phenomic Assessment in Lethal Metastatic Prostate Cancer: Recommendations for Advancing Precision Medicine.

Combined Longitudinal Clinical and Autopsy Phenomic Assessment in Lethal Metastatic Prostate Cancer: Recommendations for Advancing Precision Medicine.

Journal: European urology open science

Published: May 27, 2021

Prognostic Index for Predicting Prostate Cancer Survival in a Randomized Screening Trial: Development and Validation.

Prognostic Index for Predicting Prostate Cancer Survival in a Randomized Screening Trial: Development and Validation.

Journal: Cancers

Published: November 24, 2020

Number of screening rounds attended and incidence of high-risk prostate cancer in the Finnish Randomized Study of Screening for Prostate Cancer (FinRSPC).

Number of screening rounds attended and incidence of high-risk prostate cancer in the Finnish Randomized Study of Screening for Prostate Cancer (FinRSPC).

Journal: Cancer

Published: July 02, 2020

Showing 1-12 of 56

Last Updated: 09/26/2026